CN112645884B - Synthetic method of 3, 6-difluoro-4-methylpyridazine - Google Patents

Synthetic method of 3, 6-difluoro-4-methylpyridazine Download PDF

Info

Publication number
CN112645884B
CN112645884B CN202110158961.5A CN202110158961A CN112645884B CN 112645884 B CN112645884 B CN 112645884B CN 202110158961 A CN202110158961 A CN 202110158961A CN 112645884 B CN112645884 B CN 112645884B
Authority
CN
China
Prior art keywords
methylpyridazine
difluoro
dichloro
organic solvent
potassium fluoride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110158961.5A
Other languages
Chinese (zh)
Other versions
CN112645884A (en
Inventor
刘超
史建云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alibaba Biological New Materials Changzhou Co Ltd
Original Assignee
Alibaba Biological New Materials Changzhou Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alibaba Biological New Materials Changzhou Co Ltd filed Critical Alibaba Biological New Materials Changzhou Co Ltd
Priority to CN202110158961.5A priority Critical patent/CN112645884B/en
Publication of CN112645884A publication Critical patent/CN112645884A/en
Application granted granted Critical
Publication of CN112645884B publication Critical patent/CN112645884B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Abstract

The invention belongs to the technical field of medical intermediates, and particularly relates to a synthetic method of 3, 6-difluoro-4-methylpyridazine. The synthesis method comprises the step of taking 3, 6-dichloro-4-methylpyridazine as a raw material, and reacting the 3, 6-dichloro-4-methylpyridazine with potassium fluoride in an organic solvent to obtain the 3, 6-difluoro-4-methylpyridazine.

Description

Synthetic method of 3, 6-difluoro-4-methylpyridazine
Technical Field
The invention belongs to the technical field of medical intermediates, and particularly relates to a synthetic method of 3, 6-difluoro-4-methylpyridazine.
Background
Pyridazine is an important aromatic ring compound, is widely found in natural product medical intermediates and pesticides, and has strong physiological activities of resisting virus, reducing blood pressure and the like. In the prior art, the synthesis process of the pyridazine ring is complex and has low yield, and research and improvement on the synthesis process become necessary.
3, 6-difluoro-4-methylpyridazine is one kind of pyridazine, and its synthesis process and relevant derivative have wide application in medicinal chemistry and organic synthesis. At present, the synthesis method of 3, 6-difluoro-4-methylpyridazine has few reports in documents. Therefore, it is necessary to develop a synthesis method which has easily available raw materials, convenient operation, easy control of reaction, proper overall yield and suitability for industrial production.
Disclosure of Invention
The technical problems to be solved by the invention are as follows: in order to solve the problems, a method for synthesizing 3, 6-difluoro-4-methylpyridazine is provided.
In order to solve the technical problems, the invention adopts the following technical scheme:
a synthetic method of 3, 6-difluoro-4-methylpyridazine, wherein the structure of the 3, 6-difluoro-4-methylpyridazine is as follows:
Figure DEST_PATH_IMAGE001
the synthesis method comprises the step of taking 3, 6-dichloro-4-methylpyridazine as a raw material, and reacting the 3, 6-dichloro-4-methylpyridazine with potassium fluoride in an organic solvent to obtain the 3, 6-difluoro-4-methylpyridazine.
The synthesis method comprises the steps of adding 3, 6-dichloro-4-methylpyridazine, potassium fluoride and an organic solvent into a reactor, heating to 130-140 ℃ under the protection of nitrogen, and reacting to obtain the 3, 6-difluoro-4-methylpyridazine.
The organic solvent is N, N-dimethylformamide.
The mass ratio of the potassium fluoride to the 3, 6-dichloro-4-methylpyridazine is 1-3: 1.
The solid-liquid g/mL ratio of the 3, 6-dichloro-4-methylpyridazine to the organic solvent is 1: 5-9.
Compared with other methods, the method has the beneficial technical effects that:
(1) the invention provides a synthetic method of 3, 6-difluoro-4-methylpyridazine, and provides a synthetic route for the synthetic method of 3, 6-difluoro-4-methylpyridazine;
(2) the synthetic method of the 3, 6-difluoro-4-methylpyridazine is short in route, reasonable in design, simple to operate and easy to control;
(3) the product obtained by the method has high yield.
Detailed Description
The organic solvent is N, N-dimethylformamide.
A synthesis method of 3, 6-difluoro-4-methylpyridazine comprises the steps of taking materials according to the mass ratio of potassium fluoride to 3, 6-dichloro-4-methylpyridazine of 1-3: 1, 3, 6-dichloro-4-methylpyridazine and the solid-liquid g/mL ratio of an organic solvent of 1: 5-9, adding 3, 6-dichloro-4-methylpyridazine, potassium fluoride and the organic solvent into a reactor, carrying out nitrogen protection, heating to 130-140 ℃, and reacting for 4-8 hours to obtain the 3, 6-difluoro-4-methylpyridazine.
Example 1
The organic solvent is N, N-dimethylformamide.
A synthesis method of 3, 6-difluoro-4-methylpyridazine comprises the steps of adding 100g of 3, 6-dichloro-4-methylpyridazine, 110g of potassium fluoride and 850mL of organic solvent into a reactor, heating to 135 ℃ under the protection of nitrogen, reacting for 6 hours, detecting by TLC, finishing the reaction of raw materials, filtering, distilling mother liquor under reduced pressure (external temperature 70 ℃), distilling to obtain a mixture of a product and DMF, adding the distilled fraction into 1000mL of water, extracting with ethyl acetate (1000 mL of 2), concentrating, loading the mixture to a column by a wet method, collecting a product spot, and concentrating to obtain 75.6g of light yellow oily matter, namely the 3, 6-difluoro-4-methylpyridazine, wherein the yield is 94.7%, and the purity is 97.6%.
1H NMR(CDCl3): 7.18(dd, J=6.8, 0.8Hz, 1H), 2.41(s, 3H)。
Example 2
The organic solvent is N, N-dimethylformamide.
A synthesis method of 3, 6-difluoro-4-methylpyridazine comprises the steps of adding 100g of 3, 6-dichloro-4-methylpyridazine, 110g of potassium fluoride and 850mL of organic solvent into a reactor, heating to 140 ℃ under the protection of nitrogen, reacting for 8 hours, detecting by TLC, finishing the reaction of raw materials, filtering, distilling mother liquor under reduced pressure (external temperature 70 ℃), distilling to obtain a mixture of a product and DMF, adding the distilled fraction into 1000mL of water, extracting with ethyl acetate (1000 mL of 2), concentrating, loading by a wet method, passing through a column, collecting a product point, and concentrating to obtain 77.2g of light yellow oily matter, namely the 3, 6-difluoro-4-methylpyridazine, wherein the yield is 96.7% and the purity is 98.8%.
1H NMR(CDCl3): 7.18(dd, J=6.8, 0.8Hz, 1H), 2.41(s, 3H)。
Example 3
The organic solvent is N, N-dimethylformamide.
A synthesis method of 3, 6-difluoro-4-methylpyridazine comprises the steps of adding 100g of 3, 6-dichloro-4-methylpyridazine, 110g of potassium fluoride and 850mL of organic solvent into a reactor, heating to 130 ℃ under the protection of nitrogen, reacting for 4 hours, detecting by TLC, finishing the reaction of raw materials, filtering, distilling mother liquor under reduced pressure (external temperature 70 ℃), distilling to obtain a mixture of a product and DMF, adding the distilled fraction into 1000mL of water, extracting with ethyl acetate (1000 mL of 2), concentrating, loading the mixture to a column by a wet method, collecting a product spot, and concentrating to obtain 76.5g of light yellow oily matter, namely the 3, 6-difluoro-4-methylpyridazine, wherein the yield is 95.8% and the purity is 99.1%.
1H NMR(CDCl3): 7.18(dd, J=6.8, 0.8Hz, 1H), 2.41(s, 3H)。

Claims (5)

1. A synthetic method of 3, 6-difluoro-4-methylpyridazine, wherein the structure of the 3, 6-difluoro-4-methylpyridazine is as follows:
Figure DEST_PATH_IMAGE002
the synthesis method is characterized in that 3, 6-dichloro-4-methylpyridazine is used as a raw material, and potassium fluoride and the 3, 6-dichloro-4-methylpyridazine react in an organic solvent to obtain the 3, 6-difluoro-4-methylpyridazine.
2. The method for synthesizing 3, 6-difluoro-4-methylpyridazine according to claim 1, wherein the method comprises the steps of adding 3, 6-dichloro-4-methylpyridazine, potassium fluoride and an organic solvent into a reactor, heating to 130-140 ℃ under the protection of nitrogen, and reacting to obtain 3, 6-difluoro-4-methylpyridazine.
3. The method for synthesizing 3, 6-difluoro-4-methylpyridazine according to claim 1 or 2, wherein the organic solvent is N, N-dimethylformamide.
4. The method for synthesizing 3, 6-difluoro-4-methylpyridazine according to claim 1 or 2, wherein the mass ratio of the potassium fluoride to the 3, 6-dichloro-4-methylpyridazine is 1-3: 1.
5. The method for synthesizing 3, 6-difluoro-4-methylpyridazine according to claim 1 or 2, wherein the solid-liquid g/mL ratio of the 3, 6-dichloro-4-methylpyridazine to the organic solvent is 1:5 to 9.
CN202110158961.5A 2021-02-05 2021-02-05 Synthetic method of 3, 6-difluoro-4-methylpyridazine Active CN112645884B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110158961.5A CN112645884B (en) 2021-02-05 2021-02-05 Synthetic method of 3, 6-difluoro-4-methylpyridazine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110158961.5A CN112645884B (en) 2021-02-05 2021-02-05 Synthetic method of 3, 6-difluoro-4-methylpyridazine

Publications (2)

Publication Number Publication Date
CN112645884A CN112645884A (en) 2021-04-13
CN112645884B true CN112645884B (en) 2022-03-11

Family

ID=75370886

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110158961.5A Active CN112645884B (en) 2021-02-05 2021-02-05 Synthetic method of 3, 6-difluoro-4-methylpyridazine

Country Status (1)

Country Link
CN (1) CN112645884B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102432545A (en) * 2011-11-22 2012-05-02 太仓市运通化工厂 Method for synthetizing 3-amino-6-methylpyridazine
CN104447569A (en) * 2014-11-05 2015-03-25 定陶县友帮化工有限公司 Method for synthetizing 3,6-dichloropyridazine
CN104788384A (en) * 2015-03-31 2015-07-22 山东友帮生化科技有限公司 Synthesis method of 3-hydroxy-6-chloropyridazine
CN105254633A (en) * 2015-09-29 2016-01-20 山东友帮生化科技有限公司 Synthesis method of imidazo[1, 2-b]pyridazine-3-carbonitrile
CN110240568A (en) * 2019-04-01 2019-09-17 兰州大学 Three replace pyridazine analog derivative and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102432545A (en) * 2011-11-22 2012-05-02 太仓市运通化工厂 Method for synthetizing 3-amino-6-methylpyridazine
CN104447569A (en) * 2014-11-05 2015-03-25 定陶县友帮化工有限公司 Method for synthetizing 3,6-dichloropyridazine
CN104788384A (en) * 2015-03-31 2015-07-22 山东友帮生化科技有限公司 Synthesis method of 3-hydroxy-6-chloropyridazine
CN105254633A (en) * 2015-09-29 2016-01-20 山东友帮生化科技有限公司 Synthesis method of imidazo[1, 2-b]pyridazine-3-carbonitrile
CN110240568A (en) * 2019-04-01 2019-09-17 兰州大学 Three replace pyridazine analog derivative and preparation method thereof

Also Published As

Publication number Publication date
CN112645884A (en) 2021-04-13

Similar Documents

Publication Publication Date Title
EP3044212B1 (en) Process for the large scale production of 1h- [1,2,3]triazole and its intermediate 1-benzyl-1h-[1,2,3]triazole
CN111646922B (en) Synthetic method of 2- (4-bromo-2-cyano-6-fluorophenyl) acetic acid
CN115772155A (en) Preparation method of alpha-lipoic acid intermediate
CN111943854B (en) Synthetic method of 3, 4-dichloro-2-nitrobenzoic acid
CN112645884B (en) Synthetic method of 3, 6-difluoro-4-methylpyridazine
CN112645833A (en) Synthesis method of (S) -2, 6-diamino-5-oxohexanoic acid
CN110551052A (en) Preparation method of (R) -4-hydroxy-2-oxo-1-pyrrolidine acetate
CN111675659B (en) Synthesis method of (5-fluoropyrimidine-4-yl) methanol
CN111269149B (en) Production process of 5- (3,3-dimethylguanidino) -2-oxopentanoic acid
AU2017333054A1 (en) Method for preparing phenylalanine compound
CN110092751B (en) Synthesis method of 2-alkyl quinoline
CN109369553B (en) Method for synthesizing N-3-isoxazole carbamic acid tert-butyl ester
CN112979565B (en) Synthetic method of 2-chloro-5- (difluoromethoxy) pyrazine
CN110028409B (en) Polysubstituted naphthalene derivative and preparation method thereof
CN111793037A (en) Crystallization and purification method of favipiravir key intermediate 3, 6-difluoropyrazine-2-carbonitrile
CN112574040B (en) Synthesis method of ethyl 2, 3-dichloro-4-nitrobenzoate
CN112125790A (en) Synthesis method of 7-chloro-1-naphthaldehyde
CN110746340A (en) Synthetic method of 5-methoxy-2-methyltryptamine
CN110922355A (en) Preparation method of nicorandil
CN112679361B (en) Synthetic method of 3-fluoro-5-nitropyridine-2-formaldehyde
CN116178216B (en) Method for synthesizing EP impurity P of aminosalicylic acid
CN110981702B (en) Efficient synthesis method of 2, 3-dibromophenol or derivatives thereof
CN112142629B (en) Preparation method of 3-aminosulfonylalanine
CN110563687B (en) Preparation method of 4- (aminomethyl) chroman-3-ol
CN108358820B (en) Preparation method of high-quality fudosteine raw material medicine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant